Cargando…
Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer’s disease
BACKGROUND: The amyloid precursor protein (APP) is a transmembrane glycoprotein that undergoes alternative proteolytic processing. Its processing through the amyloidogenic pathway originates a large sAPPβ ectodomain fragment and the β-amyloid peptide, while non-amyloidogenic processing generates sAP...
Autores principales: | Boix, Claudia P., Lopez-Font, Inmaculada, Cuchillo-Ibañez, Inmaculada, Sáez-Valero, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425076/ https://www.ncbi.nlm.nih.gov/pubmed/32787955 http://dx.doi.org/10.1186/s13195-020-00664-9 |
Ejemplares similares
-
Heteromers of amyloid precursor protein in cerebrospinal fluid
por: Cuchillo-Ibañez, Inmaculada, et al.
Publicado: (2015) -
Transmembrane Amyloid-Related Proteins in CSF as Potential Biomarkers for Alzheimer’s Disease
por: Lopez-Font, Inmaculada, et al.
Publicado: (2015) -
C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease
por: García-Ayllón, María-Salud, et al.
Publicado: (2017) -
The β-amyloid peptide compromises Reelin signaling in Alzheimer’s disease
por: Cuchillo-Ibañez, Inmaculada, et al.
Publicado: (2016) -
Beta-Amyloid Impairs Reelin Signaling
por: Cuchillo-Ibáñez, Inmaculada, et al.
Publicado: (2013)